{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:16:17Z","timestamp":1793423777350,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijrobp.2023.11.010","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:40:59Z","timestamp":1700268059000},"page":"127-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Predictive Factors for Toxicity After Primary Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3919-5135","authenticated-orcid":false,"given":"Anouk","family":"Corbeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma D.","family":"Heemsbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander C.","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Godart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carien L.","family":"Creutzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi A.","family":"Nout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.11.010_bib0001","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00428-018-2362-9","article-title":"The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology guidelines for the management of patients with cervical cancer","volume":"472","author":"Cibula","year":"2018","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0002","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ijrobp.2023.01.002","article-title":"Overall severe morbidity after chemo-radiotherapy and MRI guided adaptive brachytherapy in locally advanced cervical cancer: Results from the EMBRACE-I study","volume":"116","author":"Vittrup","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0003","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/ijgc-2018-000057","article-title":"Efficacy and toxicity of chemoradiation with image-guided adaptive brachytherapy for locally advanced cervical cancer","volume":"29","author":"Horeweg","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0004","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.21873\/invivo.12356","article-title":"Pelvic insufficiency fractures in cervical cancer after radiation therapy: A meta-analysis and review","volume":"35","author":"Chung","year":"2021","journal-title":"In Vivo"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0005","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ijrobp.2020.05.013","article-title":"Radiation-induced insufficiency fractures after pelvic irradiation for gynecologic malignancies: A systematic review","volume":"108","author":"Razavian","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0006","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ijrobp.2019.09.012","article-title":"Pelvic insufficiency fractures after external beam radiation therapy for gynecologic cancers: A meta-analysis and meta-regression of 3929 patients","volume":"106","author":"Sapienza","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0007","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): A multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109501","article-title":"Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors","volume":"181","author":"Spampinato","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0009","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S1470-2045(07)70341-8","article-title":"Gastrointestinal symptoms after pelvic radiotherapy: A new understanding to improve management of symptomatic patients","volume":"8","author":"Andreyev","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0010","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1080\/0284186X.2018.1503713","article-title":"Late gastrointestinal toxicity after radiotherapy for anal cancer: A systematic literature review","volume":"57","author":"Pan","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0011","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00384-020-03595-x","article-title":"Late gastrointestinal toxicity after radiotherapy for rectal cancer: A systematic review","volume":"35","author":"Sipaviciute","year":"2020","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0012","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1038\/s41598-022-08525-1","article-title":"Quality of life in patients treated with radiochemotherapy for primary diagnosis of anal cancer","volume":"12","author":"Sauter","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0013","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ygyno.2014.05.008","article-title":"Quality of life (QOL) in women treated for gynecologic malignancies with radiation therapy: A literature review of patient - reported outcomes","volume":"134","author":"Mirabeau-Beale","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0014","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.semradonc.2020.05.005","article-title":"Intensified systemic therapy regimens in combination with definitive radiation for treatment of cervical cancer","volume":"30","author":"Sims","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.critrevonc.2014.12.015","article-title":"Whole pelvic intensity-modulated radiotherapy for gynecological malignancies: A review of the literature","volume":"94","author":"Hymel","year":"2015","journal-title":"Criti Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0016","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ijrobp.2019.03.020","article-title":"Importance of technique, target selection, contouring, dose prescription, and dose-planning in external beam radiation therapy for cervical cancer: Evolution of practice from EMBRACE-I to II","volume":"104","author":"Berger","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0017","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3109\/0284186X.2013.813640","article-title":"A margin-of-the-day online adaptive intensity-modulated radiotherapy strategy for cervical cancer provides superior treatment accuracy compared to clinically recommended margins: A dosimetric evaluation","volume":"52","author":"Ahmad","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0018","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0019","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13014-018-1126-7","article-title":"Intensity-modulated radiation therapy for definitive treatment of cervical cancer: A meta-analysis","volume":"13","author":"Lin","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.radonc.2016.06.016","article-title":"Which cervical and endometrial cancer patients will benefit most from intensity-modulated proton therapy?","volume":"120","author":"van de Sande","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0021","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1016\/j.ijrobp.2011.07.012","article-title":"Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies","volume":"82","author":"Milby","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0022","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.radonc.2020.09.022","article-title":"Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer","volume":"154","author":"Gort","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0023","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3109\/0284186X.2016.1139179","article-title":"Dosimetric advantages of proton therapy compared with photon therapy using an adaptive strategy in cervical cancer","volume":"55","author":"van de Schoot","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0024","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijrobp.2015.10.004","article-title":"The quest for evidence for proton therapy: Model-based approach and precision medicine","volume":"95","author":"Widder","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0026","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.radonc.2020.04.012","article-title":"Key challenges in normal tissue complication probability model development and validation: Towards a comprehensive strategy","volume":"148","author":"Van den Bosch","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0027","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.seminoncol.2019.07.006","article-title":"Normal tissue complication probability (NTCP) models for modern radiation therapy","volume":"46","author":"Palma","year":"2019","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0028","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Int Med"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0029","unstructured":"Cochrane Methods Prognosis. (n.d.). FAQ | Cochrane Prognosis. Available at: https:\/\/methods.cochrane.org\/prognosis\/tools. Accessed April 13, 2023"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1000100","article-title":"Preferred reporting items for systematic reviews and meta analyses: THE PRISMA statement","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0035","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijrobp.2020.10.006","article-title":"Dose-volume effects and risk factors for late diarrhea in cervix cancer patients after radiochemotherapy with image guided adaptive brachytherapy in the EMBRACE I study","volume":"109","author":"Jensen","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0036","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ijrobp.2021.09.055","article-title":"Severity and persistency of late gastrointestinal morbidity in locally advanced cervical cancer: Lessons learned from EMBRACE-I and implications for the future","volume":"112","author":"Spampinato","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0033","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.brachy.2017.06.007","article-title":"Intermediate dose-volume parameters and the development of late rectal toxicity after MRI-guided brachytherapy for locally advanced cervix cancer","volume":"16","author":"Ujaimi","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0031","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.ijrobp.2008.12.018","article-title":"Geometrical sparing factors for the rectum and bladder in the prediction of grade 2 and higher complications after high-dose-rate brachytherapy for cervical cancer","volume":"75","author":"Chen","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0032","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00066-021-01781-6","article-title":"Early morbidity and dose-volume effects in definitive radiochemotherapy for locally advanced cervical cancer: A prospective cohort study covering modern treatment techniques","volume":"197","author":"Seppenwoolde","year":"2021","journal-title":"Strahlentherapie und Onkologie"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0034","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/IGC.0000000000001312","article-title":"The effect of body mass index and weight change on late gastrointestinal toxicity in locally advanced cervical cancer treated with intensity-modulated radiotherapy","volume":"28","author":"Lee","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0038","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.radonc.2021.01.019","article-title":"Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis","volume":"158","author":"Spampinato","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0039","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.radonc.2020.10.003","article-title":"Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis","volume":"158","author":"Spampinato","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0037","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.brachy.2022.05.003","article-title":"The association of vagina equivalent dose in 2Gy fraction (EQD(2)) to late vagina toxicity in patients of cervical cancer treated with WPRT plus IGABT","volume":"21","author":"Ruanla","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.radonc.2021.12.034","article-title":"Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study","volume":"168","author":"Westerveld","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0041","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11604-020-01039-8","article-title":"Predictive factors of posttreatment fracture by definitive radiotherapy for uterine cervical cancer","volume":"39","author":"Ishikawa","year":"2021","journal-title":"Japan J Radiol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0042","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2019.05.001","article-title":"Systematic review and meta-analysis of small bowel dose\u2013volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy","volume":"138","author":"Holyoake","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0044","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijrobp.2022.05.009","article-title":"Patient-reported bowel and urinary function in long-term survivors of squamous cell carcinoma of the anus treated with definitive intensity modulated radiation therapy and concurrent chemotherapy","volume":"114","author":"De","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0043","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.clon.2021.09.011","article-title":"Dosimetric and clinical predictors for acute and late gastrointestinal toxicity following chemoradiotherapy of locally advanced anal cancer","volume":"34","author":"Nilsson","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2022.11.018","article-title":"Evaluation of dosimetric predictors of toxicity after IMRT with concurrent chemotherapy for anal cancer","volume":"178","author":"Lukovic","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0046","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/0300891618811273","article-title":"Chemoradiation in female patients with anal cancer: Patient-reported outcome of acute and chronic side effects","volume":"105","author":"Koerber","year":"2019","journal-title":"Tumori J"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0047","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijrobp.2015.02.029","article-title":"Dosimetric predictors of radiation-induced vaginal stenosis after pelvic radiation therapy for rectal and anal cancer","volume":"92","author":"Son","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0048","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semradonc.2020.05.008","article-title":"Evidence-based dose planning aims and dose prescription in image-guided brachytherapy combined with radiochemotherapy in locally advanced cervical cancer","volume":"30","author":"Tanderup","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0049","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ijrobp.2017.01.026","article-title":"Risk factors for pelvic insufficiency fractures in locally advanced cervical cancer following intensity modulated radiation therapy","volume":"97","author":"Ramlov","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2022.10.008","article-title":"Effects of dose and dose-averaged linear energy transfer on pelvic insufficiency fractures after carbon-ion radiotherapy for uterine carcinoma","volume":"177","author":"Mori","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0051","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.clon.2020.10.013","article-title":"Sacral insufficiency fracture following pelvic radiotherapy in gynaecological malignancies: Development of a predictive model","volume":"33","author":"Mir","year":"2021","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0052","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ygyno.2023.01.005","article-title":"Vaginal changes, sexual functioning and distress of women with locally advanced cervical cancer treated in the EMBRACE vaginal morbidity substudy","volume":"170","author":"Suvaal","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0053","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5114\/jcb.2022.119427","article-title":"Prediction models for brachytherapy-induced rectal toxicity in patients with locally advanced pelvic cancers: A systematic review","volume":"14","author":"Tohidinezhad","year":"2022","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0054","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S1470-2045(22)00544-7","article-title":"Mechanisms, mitigation, and management of urinary toxicity from prostate radiotherapy","volume":"23","author":"Martin","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13014-023-02220-9","article-title":"A focused review of statistical practices for relating radiation dose-volume exposure and toxicity","volume":"18","author":"McDonald","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0056","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.114.014508","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD) the TRIPOD statement","volume":"131","author":"Collins","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0057","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/j.ijrobp.2009.08.074","article-title":"The lessons of QUANTEC: Recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome","volume":"76","author":"Jackson","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0058","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy\u20143D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0059","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac0681","article-title":"Spatial descriptions of radiotherapy dose: Normal tissue complication models and statistical associations","volume":"66","author":"Ebert","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0060","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0061","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables","volume":"332","author":"Altman","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0071","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/09674845.2018.1482734","article-title":"Impact of GSTM1, GSTT1 and GSTP1 genes polymorphisms on clinical toxicities and response to concomitant chemoradiotherapy in cervical cancer","volume":"75","author":"Abbas","year":"2018","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0078","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.urology.2020.09.011","article-title":"Urologic complications requiring intervention following high-dose pelvic radiation for cervical cancer","volume":"151","author":"Beller","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0066","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/jcm8010125","article-title":"Total reference air kerma is associated with late bowel morbidity in locally advanced cervical cancer patients treated with image-guided adaptive brachytherapy","volume":"8","author":"Bockel","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1269\/jrr.09089","article-title":"Lack of the dose-rate effect of 192Ir source activity on pelvic control and late complications after high-dose-rate brachytherapy for cervical cancer","volume":"51","author":"Chen","year":"2010","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0077","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.radonc.2022.07.009","article-title":"Vaginal 11-point and volumetric dose related to late vaginal complications in patients with cervical cancer treated with external beam radiotherapy and image-guided adaptive brachytherapy","volume":"174","author":"Dankulchai","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0074","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ijrobp.2018.11.006","article-title":"Risk factors for ureteral stricture after radiochemotherapy including image guided adaptive brachytherapy in cervical cancer: Results from the EMBRACE studies","volume":"103","author":"Fokdal","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0062","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ijrobp.2009.11.002","article-title":"Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy","volume":"79","author":"Georg","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0064","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1748-717X-8-28","article-title":"A prospective observational study with dose volume parameters predicting rectosigmoidoscopic findings and late rectosigmoid bleeding in patients with uterine cervical cancer treated by definitive radiotherapy","volume":"8","author":"Kim","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0076","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2015.12.025","article-title":"Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study","volume":"118","author":"Kirchheiner","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0072","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ijrobp.2018.02.004","article-title":"Risk of late urinary complications following image guided adaptive brachytherapy for locally advanced cervical cancer: Refining bladder dose-volume parameters","volume":"101","author":"Manea","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0068","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.canrad.2016.05.011","article-title":"Comparison of dosimetric parameters and acute toxicity of intensity-modulated and three-dimensional radiotherapy in patients with cervix carcinoma: A randomized prospective study","volume":"20","author":"Naik","year":"2016","journal-title":"Cancer Radiotherapie"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0070","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.7314\/APJCP.2015.16.12.5075","article-title":"Impact of treatment time on chemoradiotherapy in locally advanced cervical carcinoma","volume":"16","author":"Pathy","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0073","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2020.10.010","article-title":"Ureteral stenosis after 3D MRI-based brachytherapy for cervical cancer - Have we identified all the risk factors?","volume":"155","author":"Rodriguez-Lopez","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0069","first-page":"e21000","article-title":"A prospective randomized study of intensity-modulated radiation therapy versus three-dimensional conformal radiation therapy with concurrent chemotherapy in locally advanced carcinoma cervix","volume":"14","author":"Sharma","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.ijrobp.2023.11.010_bib0075","article-title":"Using new vaginal doses evaluation system to assess the dose-effect relationship for vaginal stenosis after definitive radio(chemo)therapy for cervical cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623081336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623081336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T05:32:52Z","timestamp":1729143172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623081336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0360301623081336"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.11.010","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive Factors for Toxicity After Primary Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}